Peter Marks (Greg Nash/Pool via AP Images)

Covid-19 roundup: Ear­ly fall ap­proval date of Pfiz­er-BioN­Tech jab still an­tic­i­pat­ed; EU buys 200M dos­es of No­vavax vac­cine

The FDA has set an un­of­fi­cial dead­line to ful­ly ap­prove the Pfiz­er-BioN­Tech by La­bor Day, the New York Times re­port­ed Wednes­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.